Vitamin D effects on B cell function in autoimmunity (Q38206792)

31 August 2017

Vitamin D effects on B cell function in autoimmunity (English)

1 reference

31 August 2017

0 references

0 references

Anne-Hilde Muris

2

0 references

author name string

Linda Rolf

series ordinal

1

1 reference

31 August 2017

Raymond Hupperts

series ordinal

3

1 reference

31 August 2017

Jan Damoiseaux

series ordinal

4

1 reference

31 August 2017

language of work or name

English

0 references

publication date

24 April 2014

1 reference

Annals of the New York Academy of Sciences

31 August 2017

1 reference

31 August 2017

1317

1 reference

31 August 2017

84-91

1 reference

Vitamin D and human health: lessons from vitamin D receptor null mice.

31 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

The roles of vitamin D in skeletal muscle: form, function, and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

21 January 2018

Vitamin D: beyond bone

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Vitamin D as a T-cell modulator in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Effects of vitamin D on the peripheral adaptive immune system: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Autoimmune mediated neuromuscular junction defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Bullous skin diseases: classical types of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

The double life of a B-1 cell: self-reactivity selects for protective effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

B-cell targeting in rheumatoid arthritis and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

B Cell in Autoimmune Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Immune regulatory function of B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

B cells regulate autoimmunity by provision of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Prevention of arthritis by interleukin 10-producing B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Vitamin D: A millenium perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Existing and potentially novel functional markers of vitamin D status: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Enzymes involved in the activation and inactivation of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Vitamin D levels and food and environmental allergies in the United States: results from the National Health and Nutrition Examination Survey 2005-2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

The association between serum vitamin D level and immunoglobulin E in Korean adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Primary immune deficiencies with aberrant IgE production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12440

21 January 2018

Identifiers

DOI

10.1111/NYAS.12440

1 reference

31 August 2017

1 reference